[Normurat (benzbromaron) in the treatment of gout].
The anti-hyperuricemic effect of a daily doses of 100 mg of the normurat (Benzbromaron) was studied in 25 patients with gout. This agent leads to a rapid decrease to normal values of the elevated serum uric acid level. Within one week of discontinuation of the drug the serum urate levels rose to the initial pathological value. For some of the patients it was possible to keep the uric acid level within the normal range by administration of 50 mg of Benzbromaron daily or 100 mg every second day. The tolerance of the preparation was good and during the 4--6 months' long therapeutic trial there were no severe side effects.
D000328:Adult; D001553:Benzbromarone / Q000627:therapeutic use*; D001572:Benzofurans / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood
D001572:Benzofurans; D014527:Uric Acid; D001553:Benzbromarone
Normurat (Benzbromaron) in der Gichtbehandlung.